These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26736495)

  • 1. Shear-mediated platelet activation in patients implanted with continuous flow LVADs: A preliminary study utilizing the platelet activity state (PAS) assay.
    Valerio L; Consolo F; Bluestein D; Tran P; Slepian M; Redaelli A; Pappalardo F
    Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():1255-8. PubMed ID: 26736495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shear-Mediated Platelet Activation Enhances Thrombotic Complications in Patients With LVADs and Is Reversed After Heart Transplantation.
    Consolo F; Sferrazza G; Motolone G; Pieri M; De Bonis M; Zangrillo A; Redaelli A; Slepian MJ; Pappalardo F
    ASAIO J; 2019; 65(4):e33-e35. PubMed ID: 29952802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation is a preoperative risk factor for the development of thromboembolic complications in patients with continuous-flow left ventricular assist device.
    Consolo F; Sferrazza G; Motolone G; Contri R; Valerio L; Lembo R; Pozzi L; Della Valle P; De Bonis M; Zangrillo A; Fiore GB; Redaelli A; Slepian MJ; Pappalardo F
    Eur J Heart Fail; 2018 Apr; 20(4):792-800. PubMed ID: 29282819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolysate-mediated platelet aggregation: an additional risk mechanism contributing to thrombosis of continuous flow ventricular assist devices.
    Tran PL; Pietropaolo MG; Valerio L; Brengle W; Wong RK; Kazui T; Khalpey ZI; Redaelli A; Sheriff J; Bluestein D; Slepian MJ
    Perfusion; 2016 Jul; 31(5):401-8. PubMed ID: 26590166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin has limited ability to modulate shear-mediated platelet activation associated with elevated shear stress of ventricular assist devices.
    Valerio L; Tran PL; Sheriff J; Brengle W; Ghosh R; Chiu WC; Redaelli A; Fiore GB; Pappalardo F; Bluestein D; Slepian MJ
    Thromb Res; 2016 Apr; 140():110-117. PubMed ID: 26938158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Different Antithrombotic Regimens on Platelet-Mediated Thrombin Generation in Patients with Left Ventricular Assist Devices.
    Consolo F; Pozzi L; Pieri M; Della Valle P; Redaelli A; D'Angelo A; Pappalardo F
    ASAIO J; 2020 Apr; 66(4):415-422. PubMed ID: 31453830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of in vitro hemolysis and platelet activation of a newly developed maglev LVAD and two clinically used LVADs with human blood.
    Berk ZBK; Zhang J; Chen Z; Tran D; Griffith BP; Wu ZJ
    Artif Organs; 2019 Sep; 43(9):870-879. PubMed ID: 31001834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and In Vitro Evidence That Subclinical Hemolysis Contributes to LVAD Thrombosis.
    Bartoli CR; Zhang D; Kang J; Hennessy-Strahs S; Restle D; Howard J; Redline G; Bermudez C; Atluri P; Acker MA
    Ann Thorac Surg; 2018 Mar; 105(3):807-814. PubMed ID: 28942075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic approaches for the assessment of blood cell trauma: a focus on thrombotic risk in mechanical circulatory support devices.
    Consolo F; Dimasi A; Rasponi M; Valerio L; Pappalardo F; Bluestein D; Slepian MJ; Fiore GB; Redaelli A
    Int J Artif Organs; 2016 Jun; 39(4):184-93. PubMed ID: 27034318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-Chip Platelet Activation Assessment: Microfluidic Emulation of Shear Stress Profiles Induced by Mechanical Circulatory Support Devices.
    Mencarini T; Bozzi S; Redaelli A
    Methods Mol Biol; 2022; 2373():201-212. PubMed ID: 34520014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombotic activity of cytokine-activated endothelial cells and shear-activated platelets in the setting of ventricular assist device support.
    Apostoli A; Bianchi V; Bono N; Dimasi A; Ammann KR; Moiia YR; Montisci A; Sheriff J; Bluestein D; Fiore GB; Pappalardo F; Candiani G; Redaelli A; Slepian MJ; Consolo F
    J Heart Lung Transplant; 2019 Jun; 38(6):658-667. PubMed ID: 30846234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices.
    Gavalas MV; Breskin A; Yuzefpolskaya M; Eisenberger A; Castagna F; Demmer RT; Flannery M; Garan AR; Takeda K; Takayama H; Naka Y; Topkara VK; Colombo PC
    J Heart Lung Transplant; 2017 Jan; 36(1):59-63. PubMed ID: 27773451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfludic platforms for the evaluation of anti-platelet agent efficacy under hyper-shear conditions associated with ventricular assist devices.
    Dimasi A; Rasponi M; Consolo F; Fiore GB; Bluestein D; Slepian MJ; Redaelli A
    Med Eng Phys; 2017 Oct; 48():31-38. PubMed ID: 28869117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the Use of the Platelet Activity State Assay for the In Vitro Quantification of Platelet Activation in Blood Recirculating Devices for Extracorporeal Circulation.
    Consolo F; Valerio L; Brizzola S; Rota P; Marazzato G; Vincoli V; Reggiani S; Redaelli A; Fiore G
    Artif Organs; 2016 Oct; 40(10):971-980. PubMed ID: 26748664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress induced modulation of platelet integrin α2bβ3 expression and shedding may predict the risk of major bleeding in heart failure patients supported by continuous flow left ventricular assist devices.
    Mondal NK; Chen Z; Trivedi JR; Sorensen EN; Pham SM; Slaughter MS; Griffith BP; Wu ZJ
    Thromb Res; 2017 Oct; 158():140-148. PubMed ID: 28915447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of in vitro and in vivo metabolized aspirin in the DeBakey ventricular assist device.
    Sheriff J; Girdhar G; Chiu WC; Jesty J; Slepian MJ; Bluestein D
    J Thromb Thrombolysis; 2014 May; 37(4):499-506. PubMed ID: 24043375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraplatelet reactive oxygen species, mitochondrial damage and platelet apoptosis augment non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist device.
    Mondal NK; Sorensen EN; Hiivala NJ; Feller ED; Pham SM; Griffith BP; Wu ZJ
    Platelets; 2015; 26(6):536-44. PubMed ID: 25167344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The platelet hammer: In vitro platelet activation under repetitive hypershear.
    Sheriff J; Tran PL; Hutchinson M; DeCook T; Slepian MJ; Bluestein D; Jesty J
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():262-5. PubMed ID: 26736250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrovascular and microvascular function after implantation of left ventricular assist devices in end-stage heart failure: Role of microparticles.
    Sansone R; Stanske B; Keymel S; Schuler D; Horn P; Saeed D; Boeken U; Westenfeld R; Lichtenberg A; Kelm M; Heiss C
    J Heart Lung Transplant; 2015 Jul; 34(7):921-32. PubMed ID: 25980571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
    Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
    Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.